Compounds > 5-vinyl-2'-deoxyuridine
Page last updated: 2024-09-04

5-vinyl-2'-deoxyuridine and capecitabine

5-vinyl-2'-deoxyuridine has been researched along with capecitabine in 1 studies

Compound Research Comparison

Studies
(5-vinyl-2'-deoxyuridine)		Trials
(5-vinyl-2'-deoxyuridine)		Recent Studies (post-2010)
(5-vinyl-2'-deoxyuridine)		Studies
(capecitabine)		Trials
(capecitabine)		Recent Studies (post-2010) (capecitabine)
13145,3181,7193,282

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banken, L; Bellibas, SE; Brivet, B; Bush, ED; Chamorey, E; Kircher, C; Milano, G; Nave, S; Patel, I; Renée, N1

Trials

1 trial(s) available for 5-vinyl-2'-deoxyuridine and capecitabine

ArticleYear
Single ascending dose tolerability, pharmacokinetic-pharmacodynamic study of dihydropyrimidine dehydrogenase inhibitor Ro 09-4889.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Apr-01, Volume: 10, Issue:7

    Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Capecitabine; Deoxycytidine; Deoxyuridine; Dihydrouracil Dehydrogenase (NADP); Dose-Response Relationship, Drug; Double-Blind Method; Drug Synergism; Enzyme Inhibitors; Fluorouracil; Humans; Leukocytes, Mononuclear; Male; Models, Chemical; Placebos; Time Factors; Uracil

2004